000 01741 a2200505 4500
005 20250516104353.0
264 0 _c20121218
008 201212s 0 0 eng d
022 _a1945-7197
024 7 _a10.1210/jc.2012-2092
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoichard, A
245 0 0 _aSomatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cOct 2012
300 _aE2031-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCarcinoma, Medullary
_xgenetics
650 0 4 _aCarcinoma, Neuroendocrine
650 0 4 _aChild
650 0 4 _aExons
_xgenetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProto-Oncogene Mas
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-ret
_xgenetics
650 0 4 _aProto-Oncogene Proteins p21(ras)
_xgenetics
650 0 4 _aThyroid Neoplasms
_xgenetics
650 0 4 _aYoung Adult
650 0 4 _aras Proteins
_xgenetics
700 1 _aCroux, L
700 1 _aAl Ghuzlan, A
700 1 _aBroutin, S
700 1 _aDupuy, C
700 1 _aLeboulleux, S
700 1 _aSchlumberger, M
700 1 _aBidart, J M
700 1 _aLacroix, L
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 97
_gno. 10
_gp. E2031-5
856 4 0 _uhttps://doi.org/10.1210/jc.2012-2092
_zAvailable from publisher's website
999 _c22001755
_d22001755